Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lorus Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?

To: trustmanic who wrote (122)	4/22/1998 1:05:00 AM
From: marcos	Read Replies (1) \| Respond to of 279

I just liked imt from the chart, it's due for a pop any week now. The company just keeps rolling along getting Viruzulin onto the market. I wouldn't count out V. as a contender - even if gene therapy or some other sort of therapy takes over for the majority of treatment, there could still be a market for a soothing symptom-reliever like V. Or maybe I don't understand the technology - well, no matter, truth be told I bought it because the chart said to -g- Hadn't noticed nvn today until you said that - I let almost half go at .28 and .29 the week before last when the volume dried up on that run, and didn't replace them yet. Probably should have, but I thought it would slide off more. I really missed the boat on nrt and gns and fmi. I remember making snide remarks about nrt about a year ago, saying that it was pretty hypey. It was about .60 then -g- ..... ah well Right now I have xlx, imt, hbp, nvn, that's all - xlx has been a bit of a mistake, I'm underwater on it again after today - you were right when you said last summer that it wasn't going anywhere soon. But it will eventually, I think ............ cheers .......... marcos